Arginine Deiminase Enzyme Evolving as a Potential Antitumor Agent

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|18|4|363-368

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.18, Iss.4, 2018-01, pp. : 363-368

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bortezomib as an Antitumor Agent

By  

Current Pharmaceutical Biotechnology, Vol. 7, Iss. 6, 2006-12 ,pp. : 441-448

Bentham Science Publishers

Access to resources Recommend Favorite

The Anticancer Activity of the N-Terminal CARD-Like Domain of Arginine Deiminase (ADI) from Pseudomonas aeruginosa

By  

Letters in Drug Design & Discovery, Vol. 6, Iss. 6, 2009-09 ,pp. : 403-412

Bentham Science Publishers

Access to resources Recommend Favorite

Cantharidin as an Antitumor Agent: A Retrospective Review

By  

Current Medicinal Chemistry, Vol. 20, Iss. 2, 2013-01 ,pp. : 159-166

Bentham Science Publishers

Access to resources Recommend Favorite

Squalene: potential chemopreventive agent

By Smith T.J.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 8, 2000-08 ,pp. : 1841-1848

Informa Healthcare

Access to resources Recommend Favorite

Arginine Kinase: A Potential Pharmacological Target in Trypanosomiasis

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 14, Iss. 1, 2014-03 ,pp. : 30-36

Bentham Science Publishers

Access to resources Recommend Favorite